SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is actively trending as the community leans into its legacy as a 15-year-old parody of Bitcoin, with investors debating its long-term potential compared to serious financial assets. Discussion is largely fueled by the project's historical roots and a growing community narrative that frames the meme as an inevitable fixture in the crypto space.

Equinor ASA engages in the exploration, production, transport, refining, and marketing of petroleum and petroleum-derived products. It operates through the following segments: Exploration and Production Norway, Exploration and Production International, Exploration and Production USA, Marketing, Midstream, and Processing, Renewables, and Other. The Exploration and Production Norway segment includes the commercial development of oil and gas portfolios on the Norwegian continental shelf. The Exploration and Production International segment covers offshore and onshore activities in the USA, Mexico, and other operations worldwide. The Exploration and Production USA segment covers both onshore and offshore exploration, development, and Production of oil and gas in the USA. The Marketing, Midstream, and Processing segment markets and trades of crude oil and condensate, natural gas, NGL and refined products. The Renewables segment focuses on offshore wind, and integrated solutions for onshore renewables. The Other segment includes projects, drilling and procurement, the business area technology, digital and innovation, and corporate staffs and support functions. The company was founded on September 18, 1972 and is headquartered in Stavanger, Norway.

Equinor ASA - ADR

Equinor ASA

Equinor ASA is currently trending as investors monitor the company's role as a primary European energy supplier, with ongoing discussions focused on the impact of its North Sea infrastructure projects and natural gas distribution strategies. Market sentiment is bolstered by institutional activity surrounding dividend distributions and the company's long-term capital allocation plans, even as traders weigh the broader global energy landscape and supply-side pressures.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto is drawing intense scrutiny as investors weigh its mixed earnings and cautious outlook against a backdrop of fierce EV competition and a recent recall involving battery safety. The community remains deeply polarized, with some traders betting on a turnaround fueled by the launch of the i6 and i8 models, while others are aggressively shorting the stock, pointing to slowing sales momentum and aggressive rivalry from competitors like Nio.

Maulcoin

Maulcoin is trending as investors rally behind a community-driven, organic growth strategy, actively pushing for a breakout while anticipating airdrops and chart visibility. The community is heavily focused on holding through volatility and maintaining strong diamond hands to drive the token toward higher market capitalization milestones.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is currently the subject of intense buyout speculation, fueled by the recent FDA grant of a landmark formal evidentiary hearing for its jet lag treatment and the approval of its bipolar medication, Bysanti. While investors are actively debating the impact of management's confrontational FDA strategy and price suppression, the community is closely monitoring the stock for potential acquisition by major pharmaceutical players looking to secure its high-value pipeline.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus is attracting investor interest as a high-performance memory play, with the community highlighting its strategic role in DDR5 and CXL technologies amid ongoing data center demand. While participants debate the impact of recent supply chain issues and executive turnover, many remain bullish, viewing the company as an undervalued infrastructure provider that is well-positioned for future memory bandwidth shifts.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is gaining momentum as investors connect the stock to Alphabet's acquisition of Intersect Power, a primary customer that relies on the company's domestic utility-scale solar modules to power growing AI data center energy demands. The broader market sentiment is reacting positively to this integration, fueling community discussion around First Solar's role as a critical energy provider for large-scale technology infrastructure.

Vanguard Index Funds - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

The Vanguard Total Stock Market ETF is trending as investors debate the merit of broad market indexing versus tactical rotation strategies amid ongoing economic volatility and sector-specific concerns. Community discussions focus on the benefits of long-term capital accumulation through ETFs like VTI as a resilient hedge against market noise and speculative trading.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is currently capturing investor attention as traders debate whether its recent volatility and price compression create a prime entry point ahead of upcoming earnings. While some investors are concerned by consistent selling pressure and the stock's struggle to reclaim key resistance levels, others are highlighting the company's improved profitability, strong cash flow, and potential for an acquisition as catalysts that could drive a sharp recovery.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending as investors weigh significant balance sheet improvements, including a recent debt-to-equity conversion by leadership, against concerns over potential future dilution to fund rapid manufacturing expansion. The community is actively debating the company's long-term potential as a critical supplier for defense and aerospace giants like Anduril and SpaceX, while closely monitoring the upcoming earnings report for clarity on revenue growth and profitability timelines.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ionis Pharmaceuticals, Inc. $IONS Shares Sold by Aberdeen Group plc

Aberdeen Group plc trimmed its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 67.1% during the fourth quarter, according to the company in its most recent Form 13F...

Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price Expected to Rise, Bank of America Analyst Says

Bank of America raised their price objective on shares of Ionis Pharmaceuticals from $100.00 to $111.00 and gave the company a "buy" rating in a research report on Thursday...

Ionis Pharmaceuticals, Inc. $IONS Shares Acquired by SG Americas Securities LLC

SG Americas Securities LLC lifted its stake in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 548.7% in the 4th quarter, according to the company in its most recent Form 13F filing with...

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Given Consensus Rating of "Moderate Buy" by Analysts

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) has received an average rating of "Moderate Buy" from the twenty analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendatio...

Ionis Pharmaceuticals (NASDAQ:IONS) EVP Shannon Devers Sells 6,193 Shares

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Get Free Report) EVP Shannon Devers sold 6,193 shares of the firm's stock in a transaction on Thursday, April 2nd. The stock was sold at an average price of $74.05, for a total transaction of $458,591.65. Following the sale, the executive vice president...

J. Safra Sarasin Holding AG Purchases New Position in Ionis Pharmaceuticals, Inc. $IONS

J. Safra Sarasin Holding AG acquired a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 17,404 shares of the company's stock...

Biogen Secures FDA Nod for Higher Dose of SMA Drug Spinraza

BIIB gains after the FDA clears higher-dose Spinraza, with data showing improved motor function and potential to counter rising SMA competition.

Assenagon Asset Management S.A. Cuts Stake in Ionis Pharmaceuticals, Inc. $IONS

Assenagon Asset Management S.A. cut its holdings in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 90.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,316 shar...

Why Is Ionis Pharmaceuticals (IONS) Down 7.9% Since Last Earnings Report?

Ionis Pharmaceuticals (IONS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market

Ionis Pharmaceuticals cuts Tryngolza price ahead of sHTG decision, with analysts seeing stronger sales potential and competitive positioning.read more...

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.

IONS
Ionis Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest IONS News

IONSIonis Pharmaceuticals Inc